Compartilhar
Informação da revista
Vol. 43. Núm. S3.
Páginas S50 (Novembro 2021)
Compartilhar
Compartilhar
Baixar PDF
Mais opções do artigo
Vol. 43. Núm. S3.
Páginas S50 (Novembro 2021)
OTHER DISEASESPP 46
Open Access
DOES BLOOD TYPE HAVE AN EFFECT ON THE COURSE OF COVID-19?
Visitas
1362
Fatma YILMAZ1, Murat ALBAYRAK1, Abdülkerim YILDIZ2, Hacer Berna AFACAN ÖZTÜRK1, Senem MARAL1, Pınar AKYOL1, Merih REİS ARAS1, Buğra SAĞLAM1, Mesut TIĞLIOĞLU1
1 University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Department of Hematology
2 University of Hitit,Erol Olçok Training and Research Hospital, Department of Hematology
Este item recebeu

Under a Creative Commons license
Informação do artigo
Suplemento especial
Este artigo faz parte de:
Vol. 43. Núm S3
Mais dados
Objective

Predictive parameters that can affect the course of this infection have been the main topic of research since the beginning of the COVID-19 (Coronavirus disease 2019) pandemic. Since the discovery of blood groups, the effect of these on infectious diseases has always been of interest

Methodology

To analyze the effect of ABO blood group on mortality, hospitalization duration and  hematological and cytokine storm parameters in patients with COVID-19. This retrospective study was conducted on 140 patients diagnosed with COVID-19. Demographic characteristics, laboratory parameters including ABO blood group, complete blood count (CBC) parameters, biochemical tests, cytokine storm parameters, duration of hospitalization, and final status (discharge or death) were recorded.

Results

The 140 patients included in the analysis comprised 72 (51.4%) males and 68 (48.6%) females with a mean age of 66.3±14.0 years. . Age and gender, hospitalization duration and mortality rates were similar in all blood group types. Only D-dimer values were found to be higher in blood group A compared with other blood groups.

Conclusion

Although no difference in mortality was determined between groups,  the D-dimer level was statistically significantly higher in COVID-19 patients with A blood group.  Larger studies are needed to reflect D-dimer levels on the clinical course of infection, and thus on daily practice

O texto completo está disponível em PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Opções de artigo
Ferramentas